Razelle Kurzrock MD developed and chaired the largest Phase 1 clinical trials department in the world, while at M.D. Anderson Cancer Center. A central theme of that program was the personalized medicine strategy, embodied in a protocol PREDICT (Profile-related Evidence Determining Individualized Cancer Therapy). This approach utilized advanced molecular technologies to match patients with targeted cancer treatment.
In 2012, she moved to the University of California, San Diego Moores Cancer Center (MCC) to become Senior Deputy Center Director. Dr. Kurzrock’s also heads the newly established Center for Personalized Cancer Therapy. She serves as Director of the Clinical Trials Office, Leader of the Experimental Therapeutics Disease Team, and Chief of the Division of Hematology and Oncology, UC San Diego School of Medicine.
Dr. Kurzrock received her MD degree from the University of Toronto and has more than 525 peer-reviewed publications and a uniquely strong record of competitive grants.
“WIN is a unique organization that brings together a diversity of important stakeholders from across the globe in order to transform cancer therapy.”